Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics cash
Cash and short-term investments held at the end of each period.
Alterity Therapeutics's cash was A$37.32M at Jun 30, 2026. For fiscal 2026 it was A$37.32M, up 12.5% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is A$37.32M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$37.32M | +12.5% |
| FY2025 | Jun 30, 2025 | A$33.16M | +162.4% |
| FY2024 | Jun 30, 2024 | A$12.64M | -19.9% |
| FY2023 | Jun 30, 2023 | A$15.77M | -54.7% |
| FY2022 | Jun 30, 2022 | A$34.81M | +23.8% |
| FY2021 | Jun 30, 2021 | A$28.12M | +205.7% |
| FY2020 | Jun 30, 2020 | A$9.20M | -36.1% |
| FY2019 | Jun 30, 2019 | A$14.40M | -5.5% |
| FY2018 | Jun 30, 2018 | A$15.24M | -30.4% |
| FY2017 | Jun 30, 2017 | A$21.88M | -23.5% |
| FY2016 | Jun 30, 2016 | A$28.59M | -18.1% |
| FY2015 | Jun 30, 2015 | A$34.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$37.32M | +7.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$33.16M | -10.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$12.64M | -55.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$15.77M | -55.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$34.81M | +278.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | A$37.00M | +203.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$28.12M | +95.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | A$35.04M | +130.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$9.20M | -58.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | A$12.18M | -57.4% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$14.40M | -58.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$15.24M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$21.88M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$28.59M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | A$34.91M | – |
See a number that looks wrong?